Quarterly ResultJul 29, 2026, 04:23 PM
Bausch + Lomb Q2 Revenue $1.39B; Net Loss Improves to $(14)M
AI Summary
Bausch + Lomb reported Q2 2026 revenues of $1.39 billion, an increase from $1.28 billion in Q2 2025. The company significantly reduced its net loss, reporting $(14) million for the quarter, compared to $(62) million in the prior year period. For the six months ended June 30, 2026, revenues reached $2.64 billion, and net cash provided by operating activities increased substantially to $185 million. The company continues to evaluate the separation from Bausch Health Companies Inc.
Key Highlights
- Q2 2026 total revenues were $1.39 billion, up from $1.28 billion in Q2 2025.
- Q2 2026 net loss attributable to Bausch + Lomb improved to $(14) million.
- Basic and diluted loss per share for Q2 2026 was $(0.04), an improvement from $(0.18).
- Six months ended June 30, 2026, total revenues were $2.64 billion.
- Six months ended June 30, 2026, net cash provided by operating activities was $185 million.
- Bausch Health Companies Inc. holds approximately 87% of Bausch + Lomb's common shares.
Price Impact
More from BLCO